[go: up one dir, main page]

WO1988007367A3 - Derives de melatonine pour stress psychogene et anxiete aigue, et medicaments immuno-stimulants - Google Patents

Derives de melatonine pour stress psychogene et anxiete aigue, et medicaments immuno-stimulants Download PDF

Info

Publication number
WO1988007367A3
WO1988007367A3 PCT/EP1988/000270 EP8800270W WO8807367A3 WO 1988007367 A3 WO1988007367 A3 WO 1988007367A3 EP 8800270 W EP8800270 W EP 8800270W WO 8807367 A3 WO8807367 A3 WO 8807367A3
Authority
WO
WIPO (PCT)
Prior art keywords
melatonin
immuno
derivatives
acute anxiety
psychogenic stress
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1988/000270
Other languages
English (en)
Other versions
WO1988007367A2 (fr
Inventor
Walter Pierpaoli
Giorgio Maestroni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cellena (Cell Engineering) AG
Original Assignee
Cellena (Cell Engineering) AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878707792A external-priority patent/GB8707792D0/en
Priority claimed from GB878707793A external-priority patent/GB8707793D0/en
Application filed by Cellena (Cell Engineering) AG filed Critical Cellena (Cell Engineering) AG
Publication of WO1988007367A2 publication Critical patent/WO1988007367A2/fr
Publication of WO1988007367A3 publication Critical patent/WO1988007367A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Utilisation de la mélatonine ou des composés chimiques actifs apparentés pour la préparation de compositions pharmaceutiques destinées au traitement du stress ou de l'anxiété aiguë ainsi que pour le renforcement de la résistance immunitaire aux infections virales et parasitaires.
PCT/EP1988/000270 1987-04-01 1988-04-01 Derives de melatonine pour stress psychogene et anxiete aigue, et medicaments immuno-stimulants Ceased WO1988007367A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8707793 1987-04-01
GB8707792 1987-04-01
GB878707792A GB8707792D0 (en) 1987-04-01 1987-04-01 Compositions containing metatonin/homologues
GB878707793A GB8707793D0 (en) 1987-04-01 1987-04-01 Compositions containing melatonin/homologues

Publications (2)

Publication Number Publication Date
WO1988007367A2 WO1988007367A2 (fr) 1988-10-06
WO1988007367A3 true WO1988007367A3 (fr) 1989-01-26

Family

ID=26292085

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1988/000270 Ceased WO1988007367A2 (fr) 1987-04-01 1988-04-01 Derives de melatonine pour stress psychogene et anxiete aigue, et medicaments immuno-stimulants

Country Status (3)

Country Link
EP (1) EP0311651A1 (fr)
AU (1) AU1494788A (fr)
WO (1) WO1988007367A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300630A3 (fr) * 1987-07-03 1990-03-28 Schering Agrochemicals Limited Mélatonine pour la régulation de la reproduction des animaux
US4945103A (en) * 1989-01-17 1990-07-31 Michael Cohen Method of treating pre-menstrual syndrome
GR900100024A (el) * 1989-01-17 1991-06-07 Amr Int Μέθοδος θεραπείας του προεμμηνορροϊκού συνδρόμου.
EP0711553A1 (fr) * 1994-08-09 1996-05-15 Mario Cagnoni Utilisation de la melatonine dans le traitement des symptÔmes articulaires de l'arthrite rhumatoide
JPWO2002060457A1 (ja) * 2001-01-24 2004-05-27 天藤製薬株式会社 抗ストレス剤

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
J. Neutral Transm., suppl. 21, 1986, H.R. Lieberman: "Behavior, sleep and melatonin", pages 233-241 *
Medical Hypotheses, volume 7, no. 6, June 1981, J. Richardson et al.: "The mechanisms of stress and immunosuppression", pages 765-780 *
Peptides, volume 2, suppl. 1, 1981, ANKHO International Inc., (US), P.C. Datta: "Effects of melatonin on startle reflex in rat", pages 155-160 *
Pharmacology Biochemistry & Behavior, volume 15, 1981, ANKHO International Inc., (US), P. Golus et al.: "The effects of melatonin on open field behavior", pages 883-885 *
Pharmacology Biochemistry & Behavior, volume 24, no. 6, June 1986, ANKHO International Inc., (US), K. Neville et al.: "Anxiolytic-like action of melatonin on acquisition but not performance of DRL", pages 1497-1502 *

Also Published As

Publication number Publication date
AU1494788A (en) 1988-11-02
WO1988007367A2 (fr) 1988-10-06
EP0311651A1 (fr) 1989-04-19

Similar Documents

Publication Publication Date Title
HUP0002224A1 (hu) Virusellenes hatású benzimidazol-származékok
MY138860A (en) Hiv protease inhibitors.
PT88930A (pt) Processo para a preparacao de novos analogos de nucleosidos e de composicoes farmaceuticas que os contem
MXPA04012965A (es) Inhibidores virales.
BR0309875A (pt) métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto
NO20052739L (no) CCR5-antagonister som medikamenter
SE0104340D0 (sv) New compounds
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
EA200700362A1 (ru) Конъюгат, содержащий антивирусное соединение, в частности ингибирующее вич, фармацевтическая композиция и набор стандартной дозы лекарственного препарата на его основе, способ ингибирования с его помощью
BRPI0409136A (pt) composto heteroaromático pentacìclico e uso medicinal do mesmo
BRPI0307351B8 (pt) composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto
DE60234577D1 (de) Pharmazeutische mischung zur behandlung von krebs, die dioxolan nukleosidanalogen enthält
NO302574B1 (no) Indolkarbazolimider og deres anvendelse
MA26435A1 (fr) Derives de benzylamine amido-substitues, leurs derives precurseurs de medicaments, leur procede de preparation, compositions pharmaceutiques les contenant et methode de traitement les utilisant.
NO954545D0 (no) Inklusjonskomplekser av taxol eller taxoter, eller taxus-ekstrakt dannet med syklodekstrin, samt fremstilling og anvendelse derav
ATE361918T1 (de) 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2- yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden
KR970705563A (ko) 항바이러스제로서의 4-(2-아미노-6-(시클로프로필아미노)-9H-푸린-9-일)-2-시클로펜텐-1-메탄올 숙시네이트(4-(2-Amino-6-(Cyclopropylamino)-9H-Purin-9-yl)-2-Cyclopentene-1-Methanol Succinate as Antiviral Agent)
BR9809234A (pt) Composto, composição farmacêutica, uso de um composto, processos para tratar ou prevenir doenças do sistema endocrinológico, para fabricar um medicamento, para preparar um composto e um conjunto, conjunto, e, uso do mesmo.
ATE234082T1 (de) Adenosin enthaltendes arzneimittel
IL88971A (en) Disubstituted pyridines, process and intermediates, their preparation and pharmaceutical compositions containing them
AP9801286A0 (en) Therapeutic compounds.
WO1988007367A3 (fr) Derives de melatonine pour stress psychogene et anxiete aigue, et medicaments immuno-stimulants
EP0328924A3 (fr) Composés de thiénotriazolodiazépine et ses applications pharmaceutiques
WO1990013281A3 (fr) Procede de suppression d'une infection par l'hiv

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE FR GB IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1988902848

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1988902848

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1988902848

Country of ref document: EP